You are here: Industry Insights > Takeda

News List

Takeda eyes up Shire pharmatimes
July 19, 2018
Takeda has revealed that it is considering making a move on Shire to add ballast to its core therapeutic areas.
CEO Weber sees China as Takeda’s second-largest business—in the long run: report fiercepharma
July 19, 2018
Takeda CEO Christophe Weber has a big ambition for its China business: to make the country its second most important market. But it’s a huge task that could take a long time to achieve—if it happens at all.
Ieon-nanodrugs announces collaboration with Takeda biospectrumasia
July 18, 2018
leon`s platform can be used from early compound screening to production of market batches. Positive results from this feasibility study could potentially result in a long-term collaboration between the companies, and additional compounds may also be consi
Takeda's Ninlaro clears Phase 3 endpoint as maintenance therapy in multiple myeloma pharmafile
July 17, 2018
After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 data for its oral proteasome inhibitor Ninlaro (ixazomib).
Takeda gets US nod for Shire buy pharmatimes
July 16, 2018
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
Shire turns down Takeda’s advances pharmatimes
July 16, 2018
Shire has now confirmed that it has thus far rejected three merger proposals from Takeda, the last one being valued at around $44 billion.
Takeda ups its offer for Shire pharmatimes
July 16, 2018
Takeda has put forward a new proposed bid for Shire, increasing the cash portion of the deal.
Takeda gets US nod for Shire buy pharmatimes
July 11, 2018
Takeda says it has received unconditional clearance from the US Federal Trade Commission for the proposed acquisition of Shire.
Takeda to buy Shire for £46 billion pharmatimes
July 09, 2018
Takeda is moving ahead with its quest to acquire UK-listed Shire, after the latter approved an offer equating to around £46 billion.
Takeda bags Japan's approval for ulcerative colitis drug biospectrumasia
July 09, 2018
Entyvio was approved in the European Union and the U.S. in May 2014 for the treatment of adults with moderately to severely active UC

Previous page 1 2 3 4 5 6 7 8 9 10 ... 28 29 Next page